The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
Open accessAbstract
In order to test the suggestion that antipsychotic drugs act by blocking dopamine receptors in the brain, the direct effects of such neuroleptic drugs were tested on the stereospecific binding of [3H]dopamine and of [3H]haloperidol to rat brain striata and their subfractions. The stereospecific component of binding was defined as that amount of [3h]dopamine or [3H]haloperidol bound in the presence of (-)-butaclamol (an inactive drug) minus that bound in the presence of (+)-butaclamol (a potent neuroleptic drug); 100 nM butaclamol was used for the [3H]haloperidol assay, while 1 muM butaclamol was used for the [3H]dopamine assay. Various antipsychotic drugs inhibited this stereospecific component in both the dopamine and haloperidol assays. These inhibitory potencies correlated with the clinical doses used for controlling schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opiate Receptor: Demonstration in Nervous Tissue
Pert, C. B., & Snyder, S. H. (1973) · Science · doi:10.1126/science.179.4077.1011 · Cited by 2,388
The Membrane Actions of Anesthetics and Tranquilizers
Seeman, P. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06931-5 · Cited by 2,246
Self-citationCarlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
DOPAMINERGIC NEURONS: EFFECT OF ANTIPSYCHOTIC DRUGS AND AMPHETAMINE ON SINGLE CELL ACTIVITY
BUNNEY, B. S., WALTERS, J. R., ROTH, R. H., & AGHAJANIAN, G. K. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29539-8 · Cited by 1,283
Seeman, P., & Lee, T. (1975) · Science · doi:10.1126/science.1145194 · Cited by 869
Self-citationSnyder, S. H., Banerjee, S. P., Yamamura, H. I., & Greenberg, D. (1974) · Science · doi:10.1126/science.184.4143.1243 · Cited by 834
Cuatrecasas, P. (1974) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.43.070174.001125 · Cited by 639
Iversen, L. L. (1975) · Science · doi:10.1126/science.2976 · Cited by 527
The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs.
van Rossum, J. M. (1966) · PubMed · Cited by 510
Heikkila, R. E., Orlansky, H., & Cohen, G. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90152-5 · Cited by 468
Clement-Cormier, Y. C., Kebabian, J. W., Petzold, G. L., & Greengard, P. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1113 · Cited by 452
Goldstein, A., Lowney, L. I., & Pal, B. K. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.8.1742 · Cited by 419
Coyle, J. T., & Snyder, S. H. (1969) · Science · doi:10.1126/science.166.3907.899 · Cited by 348
Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?
Matthysse, S. (1973) · PubMed · Cited by 341
Horn, A. S., & Snyder, S. H. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.10.2325 · Cited by 198
The displacement of membrane calcium by a local anesthetic (chlorpromazine)
Kwant, W. O., & Seeman, P. M. (1969) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(69)90194-1 · Cited by 139
Self-citationTHE DOPAMINE-RELEASING ACTIONS OF NEUROLEPTICS AND ETHANOL
Seeman, P. M., & Lee, T. (1974) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29902-5 · Cited by 109
Self-citationKarobath, M. E., & Leitich, H. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.7.2915 · Cited by 102
Seeman, P. M., Staiman, A., & Chau-Wong, M. (1974) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29901-3 · Cited by 60
Self-citationLippmann, W., Pugsley, T. A., & Merker, J. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90019-3 · Cited by 59
Bruderlein, F. T., Humber, L. G., & Voith, K. (1975) · Journal of Medicinal Chemistry · doi:10.1021/jm00236a016 · Cited by 47
The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug
Voith, K., & Herr, F. (1975) · Psychopharmacology · doi:10.1007/bf00428819 · Cited by 36
Janssen, P. A., & Ft, A. (1969) · PubMed · Cited by 25
Molecular pharmacology of beta-adrenergic receptors—A status report
Lefkowitz, R. J. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90571-1 · Cited by 22
TAYLOR, K. M. (1974) · Nature · doi:10.1038/252238a0 · Cited by 13
Butaclamol hydrochloride (AY-23,028): an early evaluation in severely ill schizophrenics.
Mielke, D. H., Dm, G., Oelsner, T., Cm, K., Wk, T., & Gh, C. (1975) · PubMed · Cited by 11
Cited by
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Self-citationDopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073
Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Metadata
- Authors
- Seeman, P., Chau-Wong, M., Tedesco, J., & Wong, K.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1975-11
- Volume
- 72
- Issue
- 11
- Pages
- 4376-4380
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2046291435
- Cited by
- 701
- References
- 27
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.